BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25632890)

  • 1. Is it safe to omit baseline bone scan for newly diagnosed prostate cancer patients?
    Wang Y; Wan F; Xu L; Zhao N; Xu Z; Wang H; Wang G; Ye D; Guo J
    Urol Int; 2015; 94(3):342-6. PubMed ID: 25632890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should bone scan be performed in Chinese prostate cancer patients at the time of diagnosis?
    Wang Y; Guo J; Xu L; Zhao N; Xu Z; Wang H; Zhu Y; Jiang S; Yang N; Yang Y; Wang G
    Urol Int; 2013; 91(2):160-4. PubMed ID: 23548369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.
    Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y
    Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.
    Al-Ghazo MA; Ghalayini IF; Al-Azab RS; Bani-Hani I; Barham A; Haddad Y
    Int Braz J Urol; 2010; 36(6):685-91; discussion 691-2. PubMed ID: 21176275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis.
    Zaman MU; Fatima N; Sajjad Z; Hashmi I; Khan K
    Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S; Liehn JC; Desoize B; Larbre H; Deltour G; Valeyre J
    Clin Nucl Med; 1991 Sep; 16(9):643-8. PubMed ID: 1718651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S; Yoshimura I; Aizawa T; Koizumi K; Akakura K; Kuyama J; Ichihara K; Yonese J; Koizumi M; Nakashima J; Fujii H
    Cancer; 2002 Feb; 94(4):964-72. PubMed ID: 11920464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?
    Pal RP; Thiruudaian T; Khan MA
    Asian J Androl; 2008 Nov; 10(6):890-5. PubMed ID: 18958353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool.
    De Nunzio C; Leonardo C; Franco G; Esperto F; Brassetti A; Simonelli G; Dente D; De Dominicis C; Tubaro A
    World J Urol; 2013 Apr; 31(2):365-9. PubMed ID: 22576696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-center study of the abnormal concentration of bone imaging agent and prostate cancer bone metastasis prediction model].
    Cheng Y; Luo LP; Hu S; Li LN; Wu C; Wu B; Wang DW
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):876-881. PubMed ID: 33113631
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
    Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
    Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Necessity analysis of bone scan in patients with newly diagnosed prostate cancer].
    Zhou JQ; Zhu Y; Yao XD; Zhang SL; Dai B; Zhang HL; Ye DW
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(4):248-51. PubMed ID: 23578501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients.
    McArthur C; McLaughlin G; Meddings RN
    Br J Radiol; 2012 Apr; 85(1012):390-4. PubMed ID: 21304009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
    Lee SH; Chung MS; Park KK; Yom CD; Lee DH; Chung BH
    World J Urol; 2012 Apr; 30(2):265-9. PubMed ID: 21779835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase.
    Wymenga LF; Boomsma JH; Groenier K; Piers DA; Mensink HJ
    BJU Int; 2001 Aug; 88(3):226-30. PubMed ID: 11488734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
    Murphy GP; Troychak MJ; Cobb OE; Bowes VA; Kenny RJ; Barren RJ; Kenny GM; Ragde H; Holmes EH; Wolfert RL
    Prostate; 1997 Oct; 33(2):141-6. PubMed ID: 9316655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.